It is a pharma private limited company based in Jaipur, Rajasthan, India, established in 2022.
2022 | Jaipur, Rajasthan, India | ActiveUnisyno Pharmaceuticals Private Limited, a active private limited company, was established on 18 May 2022 in Jaipur, Rajasthan, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24290RJ2022PTC081438. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Gulab Rai Ramchandani (Director), Pawan Kumar (Director), Ayush Yadav (Director). Past directors included Pawan Kumar. It holds ₹1.60 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop. No. 118-119, Suraj Nagar Karni Palace Road,Amarpali Marg, Jaipur, Rajasthan, 302034.
U24290RJ2022PTC081438
081438
18 May 2022
₹0.10 M
₹0.10 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Unisyno Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gulab Rai Ramchandani | Director | 09 Apr 2025 | Current |
| Pawan Kumar | Director | 09 Apr 2025 | Current |
| Ayush Yadav | Director | 18 May 2022 | Current |
| Amar Chand Kaldoliya | Director | 09 Apr 2025 | Current |
| Tara Chand Payal | Director | 30 Oct 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Nov 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Unisyno Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Unisyno Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,600,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2024 | Others | ₹1.20 M | Open |
| 02 Feb 2023 | Others | ₹0.40 M | Open |
Explore comprehensive loan charge details -
Unisyno Pharmaceuticals has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Unisyno Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unisyno Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Gulab Rai Ramchandani was appointed as a Director was appointed as a Director on 09 Apr 2025 & has been associated with this company since 8 months 9 days . was recorded as a recent event.
The activity Pawan Kumar was appointed as a Director was appointed as a Director on 09 Apr 2025 & has been associated with this company since 8 months 9 days . was completed.
Progress on Amar Chand Kaldoliya was appointed as a Director was appointed as a Director on 09 Apr 2025 & has been associated with this company since 8 months 9 days . was documented.
Tara Chand Payal was appointed as a Director was appointed as a Director on 30 Oct 2024 & has been associated with this company since 1 year 1 month . was recorded as a recent event.
Unisyno Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Unisyno Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was documented.
The CIN of Unisyno Pharmaceuticals Private Limited is U24290RJ2022PTC081438.
Unisyno Pharmaceuticals Private Limited is headquartered at Shop. No. 118-119, Suraj Nagar Karni Palace Road,Amarpali Marg, Jaipur, Rajasthan, 302034.
Unisyno Pharmaceuticals Private Limited was incorporated on 18 May 2022.
The current directors of Unisyno Pharmaceuticals Private Limited are
The primary industry of Unisyno Pharmaceuticals Private Limited is Trade.
Unisyno Pharmaceuticals Private Limited is unlisted.
The authorized capital of Unisyno Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Unisyno Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX